american medical colleges

Morris who started a chapter of the National Organization for the Reform of Marijuana Laws at Suffolk this semester is celebrating the passage of Massachusetts Ballot Question 2 which decriminalizes the possession of up to one ounce of marijuana making it a civil offense instead of a criminal one. “The next day I got to school everyone was just really excited,” Morris said. “I heard more about Question 2 than about Barack Obama winning.” Under the new law people caught with one ounce or less of marijuana in Massachusetts must forfeit the drug and pay a $100 fine. Those under the age of 18 must also complete a drug awareness program and are subject to fines of up to $1,000 if they do not complete the program within a year. Under the current law possession of marijuana is a misdemeanor that can carry up to a $500 fine and six months in jail. Under the new law which is expected to take effect in January possession of more than one ounce of marijuana is considered possession with an intent to distribute and is still a crime. The bill which passed by a margin of 65 percent to 35 percent received wide support among college students but was opposed by a broad coalition of Massachusetts lawmakers and police. Although the law has yet to be submitted to the state legislature for review - where it could still be amended or repealed - one district attorney has already said he will drop all pending simple possession marijuana cases. Thomas Nolan associate professor of criminal justice at Boston University and a 27-year veteran of the Boston Police Department said he believed decriminalization is “the right course.” Nolan who appeared in a television ad supporting Question 2 said that while he does not “condone marijuana use,” he believes it should not be a criminal offense. Nolan said 7,500 new criminal records are created each year in Massachusetts for those charged with marijuana possession and that those records can have serious consequences particularly for students receiving financial aid or looking for employment. Critics of decriminalization point to the fact that Massachusetts state law already requires judges to seal the records of first-time marijuana possession offenders after six months if they do not commit another criminal offense. However said Nolan these records are not expunged. He said that from a police perspective a sealed record gives the impression that a person has “something to hide.” Massachusetts Attorney General Martha Coakley joined with all 11 of Massachusetts’s district attorneys to oppose the bill citing public safety concerns. In an Oct. 31 press release. Coakley said the “decriminalization of marijuana will send a message to children and young adults that it is okay to use and abuse illegal substances.” “I haven’t seen any opposition (to Question 2) at all really,” said Jonathan Sussman co-president of Students for Sensible Drug Policy at Brandeis University. “I’ve pretty much seen support across the board for it. Even my Republican friends and a few professors.” Sussman said the small and “relatively young” SSDP chapter at Brandeis was not heavily involved in supporting the passage of Question 2. Last year he said they collected some signatures for petitions in support of the bill and signed up new voters. “We didn’t encounter much direct opposition,” he said. “but we did encounter a lot of apathy.” Sussman said he did not expect the new law itself to affect Brandeis students in a major way. But in response to what he calls an “arbitrary” history of enforcing substance use policies at Brandeis his group is drafting a resolution that would “officially declare drugs the lowest priority” for campus law enforcement. He said they plan to have a proposal before the Brandeis Student Union Senate by next week. Sussman said that with the recent passage of Question 2. “people are becoming more aware that drug policy reform is something we can do in college.” Morris the leader of the NORML chapter at Suffolk said that the Saturday before the election his group held a small demonstration in the Boston Commons in support of Question 2. He said passers-by expressed little opposition to the bill. Morris said that although students were surprised by the passage of the bill he did not expect the law to change the extent of marijuana use in the state. “I think it’s just going to be a relax for responsible marijuana users,” he said. “A nice breath of air like a nice sigh.” Lester Grinspoon associate professor emeritus of psychiatry at Harvard Medical School and the author of several books on positive uses of marijuana said he was “delighted” that Question 2 had passed. Grinspoon said he believes marijuana’s medical uses will bring about its legalization during the lifetime of today’s college student and that Question 2 is a step in that direction. “People are going to have an experience seeing a friend or loved one using this substance and not going wacky,” making them more comfortable about supporting legalization. Grinspoon said. Although he supported Question 2. Grinspoon said he believed marijuana should be totally decriminalized and regulated in much the same manner that alcohol is. “People have to use it responsibly,” said Grinspoon. “You don’t drink and drive you don’t smoke and drive.” Question 2 must still be approved by the Massachusetts state legislature which has 30 days to change or even prevent it from going into effect. Morris said his group is writing letters to political officials and plans to hold more small rallies to ensure the measure becomes law. Source: Brown Daily Herald. The (Brown. RI Edu)Author: Emma BerryPublished: November 12. 2008Copyright: 2008 The Brown Daily HeraldContact: Website:

Forex Groups - Tips on Trading

Related article:
http://www.cannabisnews.org/?p=135

comments | Add comment | Report as Spam

Providing up-to-date information news and original content on American Military issues. By Donna MilesAmerican Forces Press ServiceNov. 10. 2008 - As he prepares to observe his first Veterans Day as Veterans Affairs secretary. Dr. James B. Peake said he believes the United States is living up to Abraham Lincoln's pledge to care for "him who has borne the battle and his widow and his orphan." Those words from Lincoln's second inaugural address are inscribed at the entrance to the Department of Veterans Affairs headquarters here. They serve as a mantra for a VA workforce that provides healthcare to more than 7.5 million veterans and benefits to more than 3.5 million veterans. Peake said the VA is taking advantage of technology and medical breakthroughs in ways Lincoln would never have dreamed possible. "I think he would be pretty proud," Peake told American Forces Press Service. "He'd say. 'You're fulfilling the promise."A retired Army lieutenant general. Peake understands the significance of that promise in a way most Americans couldn't. He was wounded twice in battle as an infantry officer during the Vietnam War. His acceptance letter to Cornell University Medical College arrived as he was in the hospital recovering from his wounds. Following the footsteps laid by his parents -- his father a medical services officer and his mother -- an Army nurse. Peake attended medical school on an Army scholarship returned to the Army for his medical internships and residencies and built his career in Army medicine. Ultimately. Peake became the 40th Army surgeon general. Now Veterans Affairs secretary. Peake said he's gratified by continued support that ensures the VA can continue providing first-class care and benefits for veterans including those returning from combat."Since 2001 the president and Congress have provided the Department of Veterans Affairs with a 98 percent increase in funding and with the guidance and support to enable VA to honor America's debt to the men and women whose patriotic service and sacrifice have kept our nation free and prosperous," Peake said in his Veterans Day message. Health-care funding alone doubled during the past seven years he said. This funding has enabled the VA to reach out to more veterans and provide better more effective services he said listing just a few of many new initiatives. VA hired more new mental-health professionals and expanded its community-based outreach. It opened more Vet Centers and laid plans for more to come. It began putting a fleet of motor coaches into service to take counseling services closer to the veterans who need it."We are trying to appropriately leverage technology and the tools to provide access to veterans no matter where they are," Peake said. "That way it is not your address that decides whether or not you get your benefits."Meanwhile in an unprecedented move authorized by the Veterans Benefits Improvement Act of 2008 signed into law last month the VA began offering VA-guaranteed home loans to veterans with more expensive and risky subprime mortgages. Much of the VA's focus has been on care for the 850,000 newest veterans who served in Iraq and Afghanistan. The VA hired transition patient advocates to help severely wounded troops and their families work their way through the transition process and federal recovery coordinators to ensure life-long medical and rehabilitative care services and other benefits for families. More claims processors are on boar d to reduce the backlog in processing disability claims. Peake called these examples an indication that the VA is on the right track in providing care for what we called "the best educated best trained best selected military we have ever had coming back reentering society.. to become the next greatest generation."He praised the commitment of his staff – 31 percent of them veterans themselves – and called them the spirit that makes every day Veterans Day at the VA. "You see that celebrated when you go to our VA," he said. There's a special level of dedication and commitment here."Tomorrow as he attends observances at Arlington National Cemetery and the Vietnam Memorial then sits down to dinner with patients at Walter Reed Army Medical Center. Peake said he'll feel gratified to see the United States observe the commemoration President Woodrow Wilson first proclaimed as Armistice Day in 1919. He urged all Americans to recognize Veterans Day either at the 33 major national observances taking place across the country or in simpler more private ways that honor veterans and their service. "Participation in Veterans Day can be as simple as putting out the porch flag or reminding youngsters of the story of a relative who served in the military," he said. Veterans Day is as important today as ever perhaps even more so. Peake said. With just 1 percent of the U. S population serving in uniform to protect liberties for the other 99 percent. Veterans Day offers a time to reflect and remember he said."It's important for everybody to realize the debt that we owe those who serve this nation," Peake said. "Without the service of our veterans we wouldn't have the freedoms we enjoy today... Their bravery their resourcefulness and their patriotism mark them as our nation's finest citizens." Posted byLieutenant Raymond E. Foster. LAPD (ret.). MPAat Trends tactics and terrorism - Open Source Information for law Enforcement Join our Newsletter Military. Police and First Responder Equipment

Forex Groups - Tips on Trading

Related article:
http://military-online.blogspot.com/2008/11/va-secretary-america-keeps-lincolns.html

comments | Add comment | Report as Spam

MINNEAPOLIS – September 17. 2007 – Baseline data from the largest study of United States-based heart failure (HF) patients in the outpatient setting show significant gaps and variation in medical care particularly for women and the elderly. Findings from the Registry to alter the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) study were presented today in a poster session at the Heart Failure Society of America Annual Scientific Meeting. The study is sponsored by Medtronic. Inc. (NYSE:MDT). “This is the first study of its kind to document the extent to which heart failure patients in the outpatient setting are receiving optimal treatment as defined by the most recent treatment guidelines,� said Gregg C. Fonarow. MD. Co-Chair of the IMPROVE HF Scientific Steering Committee and Professor of Medicine at the University of California at Los Angeles. “The alter HF data represents real-world management of heart failure patients in a variety of outpatient cardiology practices from all regions of the United States. It shows us that there are gaps and significant variation across these practices in the use of evidence-based guideline-recommended therapies in eligible patients especially female and elderly patients,� added Fonarow. “These data signal an opportunity for the medical community to improve the quality of care for the country’s five million heart failure patients,� said Clyde Yancy. MD. Co-Chair of the alter HF Scientific Steering Committee and Medical Director at the Baylor Heart and Vascular initiate. Baylor University Medical Center in Dallas. Texas. * Substantial variation exists across outpatient cardiology practices in the type of treatment provided to heart failure patients. Conformity with performance measures (in eligible patients only) for practices (10th-90th percentiles) was: o ACE inhibitors/ARB (angiotensin II receptor blockers) (67.9-90.4%) o Beta-blockers (72.3-94.4%) o Aldosterone antagonists (7.1-63%) o Cardiac resynchronization therapy (CRT) including both CRT-Defibrillation and CRT-Pacing only devices (0-80%) o Implantable cardioverter defibrillator (ICD) therapy including both ICD only and CRT-D devices (26.3-76.2%) o Patient education (29.1-88.9%) o Anticoagulation for atrial fibrillation (AF) (44.4-87.5%) * Eligibility for certain treatments is based upon documented medical information such as New York Heart Association (NYHA) functional class; yet only 31 percent of records documented NYHA class. * Women were less likely than men to receive an implantable cardioverter defibrillator (ICD) when indicated (43.1% vs. 53%; p<0.001) education about their instruct (59.7% vs. 61.9%; p=0.026) or anticoagulation treatment for atrial fibrillation (64.8% vs. 70.6%; p=0.004). * Older patients were less likely than younger patients to acquire certain types of guideline-indicated interventions – particularly ICD/CRT-D therapy o 43% in patients >76 years o 57.2% in patients >64 to <76 years o 52% in patients <64 years; p<0.001 “Medtronic is firmly committed to advancing patient compassionate through the give of clinical investigate such as the alter HF study,� said James P. Mackin. Senior Vice President and President. Cardiac Rhythm Disease Management at Medtronic. “We’re hopeful that deeper understanding and application of treatment guidelines will ultimately help save more lives.� About IMPROVE HFIMPROVE HF is the first of its kind large-scale prospective study involving approximately 40,000 HF patients from approximately 150 cardiology practices in the U. S. The study is designed to: 1. ACE inhibitors/ARB (angiotensin II receptor blockers) 2. Beta-blockers 3. Aldosterone antagonists 4. Anticoagulation for atrial fibrillation 5. ICD therapy – including both ICD only and CRT-D devices 6. CRT therapy – including both CRT-D and CRT-P only devices 7. Heart failure patient education such as smoking cessation exercising diet and restricting flavor intake Chart reviews were conducted at baseline and as part of the ongoing study and performance improvement initiative ordain be conducted again at six. 12. 18 and 24 months. All study data is being collected and analyzed by an independent clinical investigate organization. About Heart Failure and Treatment GuidelinesHeart failure is typically a late manifestation of one or more other cardiovascular diseases including coronary artery disease (CAD) hypertension and valvular disease. Chronic heart failure occurs when the heart is unable to pump enough daub to sustain adequate circulation in the body’s tissues. Approximately 5.2 million Americans suffer from HF and more than 550,000 new cases are estimated to create each year. Heart failure is the most costly cardiovascular disease in the U. S. at an estimated $40 billion per year. Estimates for the global population (22 million) are near $80 billion. In 2001 the American College of Cardiology and American Heart Association (ACC/AHA) published the first guidelines for the evaluation and management of chronic heart failure in adults. The ACC/AHA published updated HF treatment guidelines in 2005. In 2006 the Heart Failure Society of America (HFSA) released guidelines for living with and treating HF which balance the ACC/AHA guidelines that recommend device therapy as standard of compassionate for HF patients already on optimal medical therapy who meet CRT and/or ICD indications. The use of published HF treatment guidelines has been shown to decrease the risk of death by up to 77 percent. About MedtronicMedtronic. Inc. () headquartered in Minneapolis is the global leader in medical technology – alleviating hurt restoring health and extending life for millions of populate around the world. Any statements made about anticipated regulatory analyse or approval are forward-looking statements affect to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 27. 2007. Actual results may differ materially from anticipated results.

Forex Groups - Tips on Trading

Related article:
http://www.allamericanpatriots.com/48732502_health_study_data_shows_gaps_and_variation_use_evidence_based_treatments_and_guidelines_chr

comments | Add comment | Report as Spam

Medical flip-flopsThe generally excellent bind below is from the NYT. The author is not quite up to date with the latest change by reversal though decided a few days ago that estrogen pills are good for women Once upon a time women took estrogen only to relieve the hot flashes sweating vaginal dryness and the other discomforting symptoms of menopause. In the late 1960s thanks in move to the efforts of Robert Wilson a Brooklyn gynecologist and his 1966 best seller. "Feminine Forever," this began to change and estrogen therapy evolved into a long-term remedy for the chronic ills of aging. Menopause. Wilson argued was not a natural age-related instruct; it was an illness akin to diabetes or kidney failure and one that could be treated by taking estrogen to replace the hormones that a woman's ovaries secreted in ever diminishing amounts. With this argument estrogen evolved into hormone-replacement therapy or H. R. T. as it came to be called and became one of the most popular prescription drug treatments in America. By the mid-1990s the American Heart Association the American College of Physicians and the American College of Obstetricians and Gynecologists had all concluded that the beneficial effects of H. R. T were sufficiently well established that it could be recommended to older women as a means of warding off heart disease and osteoporosis. By 2001. 15 million women were filling H. R. T prescriptions annually; perhaps 5 million were older women taking the medicate solely with the expectation that it would accept them to bring about a longer and healthier life. A year later the tide would move. In the summer of 2002 estrogen therapy was exposed as a hazard to health rather than a acquire and its story became what Jerry Avorn a Harvard epidemiologist has called the "estrogen debacle" and a "inspect study waiting to be written" on the elusive search for truth in medicine. Many explanations have been offered to alter sense of the here-today-gone-tomorrow nature of medical wisdom - what we are advised with confidence one year is reversed the next - but the simplest one is that it is the natural rhythm of science. An observation leads to a hypothesis. The hypothesis (measure year's advice) is tested and it fails this year's test which is always the most likely outcome in any scientific assay. There are after all an infinite number of do by hypotheses for every right one and so the odds are always against any particular hypothesis being true no be how obvious or vitally important it might seem. In the case of H. R. T. as with most issues of diet lifestyle and disease the hypotheses mouth their transformation into public-health recommendations only after they've received the requisite support from a handle of investigate known as epidemiology. This science evolved over the measure 250 years to make comprehend of epidemics - hence the name - and infectious diseases. Since the 1950s it has been used to identify or at least to try to identify the causes of the common chronic diseases that come about us particularly heart disease and cancer. In the process the perception of what epidemiologic investigate can legitimately accomplish - by the public the press and perhaps by many epidemiologists themselves - may have run far ahead of the reality. The case of hormone-replacement therapy for post-menopausal women is just one of the cautionary tales in the annals of epidemiology. It's a particularly glaring example of the difficulties of trying to establish reliable knowledge in any scientific handle with research tools that themselves may be unreliable. What was considered true about estrogen therapy in the 1960s and is still the case today is that it is an effective treatment for menopausal symptoms. Take H. R. T for a few menopausal years and it's extremely unlikely that any injure will go from it. The uncertainty involves the lifelong risks and benefits should a woman decide to act taking H. R. T desire past menopause. In 1985 the Nurses' Health Study run out of the Harvard Medical School and the Harvard educate of Public Health reported that women taking estrogen had only a third as many heart attacks as women who had never taken the drug. This appeared to confirm the belief that women were protected from heart attacks until they passed through menopause and that it was estrogen that bestowed that protection and this became the basis of the therapeutic wisdom for the next 17 years. Faith in the protective powers of estrogen began to erode in 1998 when a clinical trial called HERS for Heart and Estrogen-progestin Replacement Study concluded that estrogen therapy increased rather than decreased the likelihood that women who already had heart disease would experience a heart attack. It evaporated entirely in July 2002 when a second trial the Women's Health Initiative or W. H. I. concluded that H. R. T constituted a potential health risk for all postmenopausal women. While it might protect them against osteoporosis and perhaps colorectal cancer these benefits would be outweighed by increased risks of heart disease touch blood clots converge cancer and perhaps even dementia. And that was the final word. Or at least it was until the June 21 air of The New England Journal of care for. Now the idea is that hormone-replacement therapy may indeed protect women against heart disease if they mouth taking it during menopause but it is still decidedly deleterious for those women who mouth later in life. This latest variation does come with a caveat however which could undergo been made at any point in this history. While it is easy to find authority figures in care for and public health who will argue that today's version of H. R. T wisdom is assuredly the correct one it's equally easy to find authorities who will say that surely we don't experience. The one thing on which they will all agree is that the kind of experimental trial necessary to cause the truth would be excessively expensive and time-consuming and so ordain almost assuredly never happen. Meanwhile the question of how many women may have died prematurely or suffered strokes or converge cancer because they were taking a pill that their physicians had prescribed to protect them against heart disease lingers unanswered. A reasonable estimate would be tens of thousands. The change by reversal Rhythm of Science At the bear on of the H. R. T story is the science of epidemiology itself and in particular a kind of chew over known as a prospective or cohort chew over of which the Nurses' Health chew over is among the most renowned. In these studies the investigators observe disease rates and lifestyle factors (diet physical activity prescription medicate use exposure to pollutants etc.) in or between large populations (the 122,000 nurses of the Nurses' study for example). They then try to conclude conclusions - i e. hypotheses - about what caused the disease variations observed. Because these studies can create an enormous number of speculations about the causes or prevention of chronic diseases they provide the fodder for much of the health news that appears in the media - from the potential benefits of look for oil fruits and vegetables to the supposed dangers of sedentary lives trans fats and electromagnetic fields. Because these studies often provide the only available evidence outside the laboratory on critical issues of our well-being they have go to play a significant role in generating public-health recommendations as wellThe dangerous game being played here as David Sackett a retired Oxford University.

Forex Groups - Tips on Trading

Related article:
http://john-ray.blogspot.com/2007/09/medical-flip-flops-generally-excellent.html

comments | Add comment | Report as Spam

This blog is dedicated to documenting credible reports of anti-Semitism and anti-Zionism at colleges and universities. Its mission is to educate people about this alarming phenomenon and to work towards finding a solution. Topics discussed on this place include: anti-Semitic and anti-Zionist incidents; professors; student groups; scholarly work; academic programs; as well as terrorist groups extremists and intolerant ideologies that furnish hatred against Jews and Israel supporters on campus. Nadia Abu el Haj and cast aside DNAThe controversial Barnard College. Columbia University anthropologist. Nadia Abu el Haj has been studying genetics now for about seven years now. Most recently she has become interested in how “genetic origins emerge as a shared concern among those who may seek redress or recognition.”The fruits of this labor are beginning to appear.“The Genetic Reinscription of Race,” Annual Review of Anthropology 2007 (forthcoming)Nadia Abu El-Haj. "'A Tool to Recover Past Histories'—Genealogy and Identity after the Genome," Occasional Paper of the School of Social Science 19. December 2004. Princeton. And the paper we ordain consider here: "Rethinking Genetic Geneaology: A Response to Stephan Palmié." American Ethnologist 2007. 34:2:223-227In this cover. Abu El Haj reminds us of why early twentieth century racial science is now suspect it “presumed a causal relationship between biology and culture.”Anthropologists studying genetic genealogy do nothing of the sort. They chew over noncoding DNA known colloquially as “junk DNA.” This “work is a matter of tracing descent; this is nothing more than a mark and it has no bearing on the challenge of inherited characteristics…(noncoding DNA) cannot generate cultural behavorial or for that be truly biological differences between human groups.”This is wonderfully liberating. It enables anthropologists like Abu El Haj to chew over the genetic traces of the migrations of human groups without fearing the stigma of racism. After all the markers of noncoding DNA “displace information regarding ‘ancestry’ precisely because they are not subject to natural selection. 5 ”That “5” is the footnote number that appears at this point in Abu el Haj’s elegant little paper. Did you follow her argument? It would be racist to study any DNA that codes for something with a biological answer (such as hair color or musical ability) for clues about the history of human migrations. It is all right to study noncoding DNA because it does not label for anything biological. It’s just there as a choose of collect neutral as a court reporter taking notes on the human past with a special interest apparently in the past of the Jews. The only two human groups that be in Abu El Haj’s paper to illustrate how genetics can illuminate the history of population movements are Sally Hemmings’ great-great-grandchildren and… the Jews. Oh and when she writes on what genetics has told us about the Jews she gets it wrong. But back to footnote 5. It reads: “This is no longer the reigning understanding of noncoding regions in the mainstay of genomic disciplines (biomedical fields in particular)." Typically of Abu El Haj she knows this not because she construe the genetic literature but because someone told her so. "One genetic anthropologist told me just how much natural selection noncoding regions are subject to will alter whether the historical claims based on them (and related methodological assumptions) still hold.”Did you get that? She wrote a nice little paper. (Nice that is except for the bad facts about the Jews and the fact that it's do by. But if you ignore the facts the theory is very elegant.) And then somebody told her that the assumption upon which the paper is premised that noncoding DNA is biologically functionless is no longer valid. So her methodological assumptions do not direct. Yet she went ahead and published it. And inexplicably the American Ethnologist (edited by Abu El Haj's thesis advisor Virginia Dominguez) printed it. Will somebody at the Medical School please phone Provost Brinkley and tell him he’s nuts if he gives this woman tenure. Posted by Anti-Racist Blog: Exposing Anti-Semitism and Anti-Zionism on American College Campuses at Not all views or opinions expressed on this site are necessarily those of the author(s). Anti-Racist communicate reserves the right to evaluate or shift any comments that are racist offensive untrue annoying or disrespectful; but the fact that particular comments remain on the place in no way constitutes an endorsement of their views. If you have a big problem with a viewpoint expressed on this site please telecommunicate your concerns to

Forex Groups - Tips on Trading

Related article:
http://antiracistblog.blogspot.com/2007/09/nadia-abu-el-haj-and-junk-dna.html

comments | Add comment | Report as Spam

President Hugo Chavez threatened on Monday to take over any private schools refusing to refer to the oversight of his socialist government a act some Venezuelans fear ordain compel leftist ideology in the classroom. All Venezuelan schools both public and private must refer to state inspectors enforcing the new educational system. Those that react will be closed and nationalized. Chavez said. A new curriculum will be phased in during this educate year and new textbooks are being developed to help ameliorate "the new citizen," added Chavez's brother and education attend Adan Chavez in their televised ceremony on the first day of classes one college-level syllabus obtained by The Associated touch shows some premedical students already undergo a recommended reading list including Karl Marx's "Das Kapital" and Fidel Castro's speeches alongside traditional subjects desire biology and chemistry. The syllabus also includes quotations from Chavez and urges students to learn about slain revolutionary Ernesto "Che" Guevara and Colombian rebel chief Manuel Marulanda whose leftist guerrillas are considered a terrorist group by Colombia the U. S and European Union. Venezuelan officials argue the program at the Latin American Medical School — one in a handful of state-run colleges and universities that evince socialist ideology — as the new direction of Venezuelan higher education."We must instruct socially minded people to back up the community and that's why the revolution's socialist program is being implemented," said Zulay Campos a member of a Bolivarian State Academic equip that evaluates compliance with academic guidelines."If they attack us because we're indoctrinating well yes we're doing it because those capitalist ideas that our young people have — and that have done so much damage to our people — must be eliminated," Campos said.... Chavez's efforts to spread ideology throughout society is "typical of communist regimes at the beginning" in Russia. China and Cuba — and is aimed at "imposing a sole singular vision," sociologist Antonio Cova said. 84 females in military function have died in Iraq. FB as of October 6. 2007. There have been 3807 deaths overall. You do the math on who has taken the rounds and who has bourne the load. Those who disappoint to hit the books from history are doomed to repeat it.---------------------------------------------------------------------------------"We can’t solve problems by using the same kind of thinking we used when we created them" - Albert Einstein ---------------------------------------------------------------------------------Direct TV is the pits......... 84 females in military function have died in Iraq. FB as of October 6. 2007. There have been 3807 deaths overall. You do the math on who has taken the rounds and who has bourne the load. 84 females in military function undergo died in Iraq. FB as of October 6. 2007. There have been 3807 deaths overall. You do the math on who has taken the rounds and who has bourne the load. Those who fail to hit the books from history are doomed to repeat it.---------------------------------------------------------------------------------"We can’t solve problems by using the same kind of thinking we used when we created them" - Albert Einstein ---------------------------------------------------------------------------------Direct TV is the pits......... If only non citizens could run Chavez would win in a landslide on this forum. He certainly get more votes than Hiliary. Obama or Edwards. Kucinich/Chavez ticket. Thats the sunspotters ticket. Well assuming Chavez isn't following the traditional "tin pot dictator" learn of moving his nation's wealth into his own Swiss tip account... When Venezuela tires of him he can be a educate superintendent in Baltimore City. Or any other city in the US. They've been whining about private schools-- object the REALLY private schools desire Choate-- for a long measure.(He'll probably go on the lecture circuit though. WAY more money there. We the populate of the United States in request to form a more perfect Union establish Justice insure domestic Tranquility provide for the common defense back up the general Welfare and obtain the Blessings of Liberty to ourselves and our Posterity do decree and establish this Constitution for the United States of America. They have their own curriculum. You know that. They inform about moses allah ,and Jesus. Lets see a USA President ram Jesus Christ down the throats of Public educate Children and this forum would change integrity. But if Chavez rams his socialiam down the throats of private educate children in Venezuela its perfectly authorise. Screw their parents!If the parents protest,,,, their children ordain be taken away and the parents will be sent to mind alternating camps just like Vietnam. We the People of the United States in Order to create a more perfect Union open.

Forex Groups - Tips on Trading

Related article:
http://www.baltimoresun2.com/talk/showthread.php?t=116134

comments | Add comment | Report as Spam

To take full favor of Flickr you should use a JavaScript-enabled browser and. 17°38' 12" N. 63°15' 08" W17.636578-63.252153 for a free be or (if you're already a member). |||||||Copyright © 2007 Yahoo! Inc. All rights reserved.

Forex Groups - Tips on Trading

Related article:
http://www.flickr.com/photos/sergemelki/1263677224/

comments | Add comment | Report as Spam

'Peru's President Rises Sharply In Poll After tremble' () "President Garcia's approval rose sharply in September after falling for months as voters gave him high marks for trying to swiftly act to a devastating earthquake in August." In Spanish: see ; report 'Castro Castro Victims carry Lawsuit Against Fujimori' () "It is the first international case in Latin America on violence against women. Fujimori planned ordered and led this kill. The Castro Castro Prison case is a crime of study proportions; that is why there is a demand to carry Fujimori to justice." Dr. Mark Rego. Member. Peruvian American Medical Society Responds to Pain Article (earn. ) "I undergo worked for several years supporting and developing a remove mental health clinic for the poor of Ayacucho. Peru." cf. '4 Peruvians Deported For Using RP In Sneaking Into Canada' (. Martaux Ortix) "Four Peruvian nationals have been deported for attempting to use the Philippines as a jump-off inform to enter Canada illegally. Immigration Commissioner Marcelino Libanan said in a statement he ordered the Peruvians placed on the immigration blacklist to prevent their reentry into the country." 'I've Got To Draw A Line A Snorting Gourmet Cocaine' (. UK. Caitlin Moran) "More affluent customers meanwhile go for a much higher quality Peruvian cocaine. ... Specifying “Peruvian cocaine� – like it’s “Madagascan vanilla essence,� or “the wines of the Loire. It makes you appear like you know a little bit about the provenance." 'Gene Savoy. 80; Uncovered Ancient Ruins' ( using Associated Press. Martin Griffith)

Forex Groups - Tips on Trading

Related article:
http://peruvia.blogspot.com/2007/09/politics-perus-president-rises-sharply.html

comments | Add comment | Report as Spam

September 18. 2007 -- Genzyme Corp. (Nasdaq: GENZ) today broke fasten on a significant expansion of its flagship manufacturing facility at Allston Landing in Boston. The $150 million project is focused on adding space for manufacturing give functions and ordain allow for the creation of 90 jobs. The expansion was marked by a ceremony featuring Massachusetts Governor Deval L. Patrick. Boston Mayor Thomas M. Menino and five-year-old Pompe patient Megan Assink along with her parents. Greg and Deb and her sister. Hope. The event was attended by more than 500 people including local political and business leaders members of the Allston community patient organizations foreign government officials and Genzyme employees. Commercial production of a hit product began at Allston Landing in 1996; Genzyme has since introduced four additional products to the facility. This substantial growth in manufacturing capacity has led to the be for greater space for manufacturing support operations offices and mechanical equipment. "The expansion of Allston Landing ordain help sustain the continued growth of Genzyme's products," said Henri A. Termeer chairman and chief executive command of Genzyme. "It will alter us to continue to fulfill our long-term commitment to mouth these life-saving treatments to patients around the world." Allston Landing was Genzyme’s first major manufacturing facility and is now one of 17 worldwide. Thousands of patients rely on the medicines produced at Allston which is one of the world's largest cell-culture manufacturing facilities. The expansion project includes 86,000 form feet of new office and manufacturing-support space. Genzyme is also building a 26,000 form foot underground co-generation facility which will generate steam to run the lay’s affect operations and ordain also create electricity. Genzyme began construction of Allston Landing in the early 1990s and the facility was initially intended to produce one product— Cerezyme® (imiglucerase for injection) for Type 1 Gaucher disease. While the physical coat and layout of the facility have remained largely unchanged. Genzyme is now producing five products at the facility. Three are manufactured there: Cerezyme; Fabrazyme® (agalsidase beta) for Fabry disease; and Myozyme® (alglucosidase alfa) for Pompe disease. Genzyme also performs the filling and packaging for two products manufactured at other sites: Aldurazyme® (laronidase) for MPS I disease and Thyrogen® (thyrotropin alfa for injection) used in the screening of patients who have had thyroid cancer. Genzyme measure expanded the place in 2004. The Allston Landing facility is a highly visible landmark located between Storrow Drive and the Massachusetts Turnpike. The create by mental act and brick façade of the existing building establish a strong visual link to nearby universities. The expanded site has been designed to designate a significantly more modern and transparent image in keeping with Genzyme’s continuing wish to embrace these qualities in its corporate culture. The design also ordain answer to symbolically change state up the facility to the surrounding community. The Allston expansion ordain incorporate environmentally responsible building practices similar to those used in Genzyme bear on—the company’s Cambridge headquarters—and its new Science Center in Framingham. Genzyme intends to seek certification for the expansion under the U. S. Green Building Council's LEED® (Leadership in Energy and Environmental Design) color Building Rating System™. The expanded facility will permanently house works of art from the Expression of Hope exhibition produced by populate in Massachusetts and around the world living with lysosomal storage disorders. These patients were invited to create and refer a bring home the bacon of art that expressed their feelings of hope in the approach of their struggles with a rare illness. The exhibition also features pieces created by artists from the Massachusetts College of Art who spent time with patients and produced pieces representing the spirit of these individuals. Allston Landing's more than 400 employees work around the measure. 365 days a year to verify that the therapies produced there meet optimal quality standards. Genzyme recruits and trains residents from the local community for a wide range of jobs at the facility including positions in manufacturing operations facilities engineering and quality operations. The architect for the Allston expansion communicate is ARC/Architectural Resources Cambridge Inc and the general contractor is Turner Construction Inc. The engineers are Clark. Richardson & Biskup. Careba Mott MacDonald and Tetra Tech Rizzo. The project is expected to be completed in approximately two years. As it has grown internationally. Genzyme has maintained its long-standing commitment to Massachusetts where the company was founded in 1981. Genzyme has a large and growing presence in the express which is domiciliate to nearly half of the affiliate's approximately 10,000 employees. Genzyme recently completed its new 180,000 square-foot Science Center in Framingham as come up as a 55,000 square-foot expansion of its Waltham location and the company continues to build its presence in Boston. Cambridge and Westborough. Genzyme currently occupies more than 2 million square feet of space in Massachusetts. The company has facilities across the United States and in more than 30 countries around the world. Genzyme is conducting major expansion projects in Belgium. France the United Kingdom. China and the Netherlands. One of the world's leading biotechnology companies. Genzyme is dedicated to making a major positive force on the lives of populate with serious diseases. Since 1981 the company has grown from a small start-up to a diversified enterprise with nearly 10,000 employees in locations spanning the globe and 2006 revenues of $3.2 billion. In 2007. Genzyme was chosen to acquire the National Medal of Technology the highest recognise awarded by the President of the United States for technological innovation. In 2006 and 2007. Genzyme was selected by FORTUNE as one of the “100 beat Companies to bring home the bacon for� in the United States. With many established products and services helping patients in nearly 90 countries. Genzyme is a leader in the effort to create and apply the most advanced technologies in the life sciences. The affiliate's products and services are focused on rare inherited disorders kidney disease orthopaedics cancer transplant and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields as well as immune disease infectious disease and other areas of unmet medical need. This press release contains forward-looking statements including the expectation that the expansion of Allston Landing will back up bear on the continued growth of Genzyme's products expected job creation estimates the completion of the Allston Landing expansion in two years and the certification of the expansion under the U. S. Green Building Council's color Building Rating System. These statements are affect to risks and uncertainties that could create actual results to differ materially from those projected in these forward-looking statements. These risks and uncertainties include Genzyme’s ability to obtain and maintain the requisite governmental or other approvals to apply its plans for the Allston facility and the risks and uncertainties described in reports filed.

Forex Groups - Tips on Trading

Related article:
http://www.allamericanpatriots.com/48732464_massachusetts_genzyme_begins_major_expansion_boston_manufacturing_facility

comments | Add comment | Report as Spam

September 18. 2007 -- Genzyme Corp. (Nasdaq: GENZ) today broke ground on a significant expansion of its flagship manufacturing facility at Allston Landing in Boston. The $150 million communicate is focused on adding space for manufacturing give functions and will accept for the creation of 90 jobs. The expansion was marked by a ceremony featuring Massachusetts Governor Deval L. Patrick. Boston Mayor Thomas M. Menino and five-year-old Pompe patient Megan Assink along with her parents. Greg and Deb and her sister. Hope. The event was attended by more than 500 populate including local political and business leaders members of the Allston community patient organizations foreign government officials and Genzyme employees. Commercial production of a hit product began at Allston Landing in 1996; Genzyme has since introduced four additional products to the facility. This substantial growth in manufacturing capacity has led to the need for greater space for manufacturing give operations offices and mechanical equipment. "The expansion of Allston Landing will help sustain the continued growth of Genzyme's products," said Henri A. Termeer chairman and chief executive officer of Genzyme. "It will enable us to continue to complete our long-term commitment to deliver these life-saving treatments to patients around the world." Allston Landing was Genzyme’s first major manufacturing facility and is now one of 17 worldwide. Thousands of patients rely on the medicines produced at Allston which is one of the world's largest cell-culture manufacturing facilities. The expansion project includes 86,000 square feet of new office and manufacturing-support space. Genzyme is also building a 26,000 form foot underground co-generation facility which ordain generate steam to run the lay’s process operations and will also produce electricity. Genzyme began construction of Allston Landing in the early 1990s and the facility was initially intended to produce one product— Cerezyme® (imiglucerase for injection) for write 1 Gaucher disease. While the physical size and layout of the facility have remained largely unchanged. Genzyme is now producing five products at the facility. Three are manufactured there: Cerezyme; Fabrazyme® (agalsidase beta) for Fabry disease; and Myozyme® (alglucosidase alfa) for Pompe disease. Genzyme also performs the filling and packaging for two products manufactured at other sites: Aldurazyme® (laronidase) for MPS I disease and Thyrogen® (thyrotropin alfa for injection) used in the screening of patients who have had thyroid cancer. Genzyme last expanded the place in 2004. The Allston Landing facility is a highly visible landmark located between Storrow Drive and the Massachusetts Turnpike. The create by mental act and brick façade of the existing building open a strong visual cerebrate to nearby universities. The expanded place has been designed to designate a significantly more modern and transparent image in keeping with Genzyme’s continuing desire to include these qualities in its corporate grow. The create by mental act also will answer to symbolically change state up the facility to the surrounding community. The Allston expansion will combine environmentally responsible building practices similar to those used in Genzyme Center—the affiliate’s Cambridge headquarters—and its new Science bear on in Framingham. Genzyme intends to desire certification for the expansion under the U. S. Green Building Council's LEED® (Leadership in Energy and Environmental Design) color Building Rating System™. The expanded facility ordain permanently accommodate works of art from the Expression of Hope exhibition produced by people in Massachusetts and around the world living with lysosomal storage disorders. These patients were invited to act and submit a bring home the bacon of art that expressed their feelings of hope in the face of their struggles with a rare illness. The exhibition also features pieces created by artists from the Massachusetts College of Art who spent measure with patients and produced pieces representing the spirit of these individuals. Allston Landing's more than 400 employees work around the measure. 365 days a year to verify that the therapies produced there meet optimal quality standards. Genzyme recruits and trains residents from the local community for a wide range of jobs at the facility including positions in manufacturing operations facilities engineering and quality operations. The architect for the Allston expansion communicate is ARC/Architectural Resources Cambridge Inc and the command contractor is Turner Construction Inc. The engineers are Clark. Richardson & Biskup. Careba Mott MacDonald and Tetra Tech Rizzo. The communicate is expected to be completed in approximately two years. As it has grown internationally. Genzyme has maintained its long-standing commitment to Massachusetts where the company was founded in 1981. Genzyme has a large and growing presence in the express which is home to nearly half of the company's approximately 10,000 employees. Genzyme recently completed its new 180,000 square-foot Science bear on in Framingham as come up as a 55,000 square-foot expansion of its Waltham location and the company continues to create its presence in Boston. Cambridge and Westborough. Genzyme currently occupies more than 2 million square feet of lay in Massachusetts. The company has facilities across the United States and in more than 30 countries around the world. Genzyme is conducting study expansion projects in Belgium. France the United Kingdom. China and the Netherlands. One of the world's leading biotechnology companies. Genzyme is dedicated to making a study positive impact on the lives of populate with serious diseases. Since 1981 the company has grown from a small start-up to a diversified enterprise with nearly 10,000 employees in locations spanning the globe and 2006 revenues of $3.2 billion. In 2007. Genzyme was chosen to acquire the National Medal of Technology the highest honor awarded by the President of the United States for technological innovation. In 2006 and 2007. Genzyme was selected by FORTUNE as one of the “100 Best Companies to bring home the bacon for� in the United States. With many established products and services helping patients in nearly 90 countries. Genzyme is a leader in the effort to create and bear on the most advanced technologies in the life sciences. The affiliate's products and services are focused on rare inherited disorders kidney disease orthopaedics cancer transplant and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development schedule focused on these fields as come up as immune disease infectious disease and other areas of unmet medical be. This touch channel contains forward-looking statements including the expectation that the expansion of Allston Landing will help sustain the continued growth of Genzyme's products expected job creation estimates the completion of the Allston Landing expansion in two years and the certification of the expansion under the U. S. Green Building Council's color Building Rating System. These statements are subject to risks and uncertainties that could create actual results to differ materially from those projected in these forward-looking statements. These risks and uncertainties consider Genzyme’s ability to obtain and keep the requisite governmental or other approvals to apply its plans for the Allston facility and the risks and uncertainties described in reports filed.

Forex Groups - Tips on Trading

Related article:
http://www.allamericanpatriots.com/48732464_massachusetts_genzyme_begins_major_expansion_boston_manufacturing_facility

comments | Add comment | Report as Spam